1. Home
  2. RXT vs PLYX Comparison

RXT vs PLYX Comparison

Compare RXT & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$1.40

Market Cap

120.0M

Sector

Technology

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$2.86

Market Cap

114.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RXT
PLYX
Founded
1998
2014
Country
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.0M
114.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RXT
PLYX
Price
$1.40
$2.86
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$1.61
N/A
AVG Volume (30 Days)
8.7M
4.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$2.20
52 Week High
$3.03
$48.91

Technical Indicators

Market Signals
Indicator
RXT
PLYX
Relative Strength Index (RSI) 78.57 25.90
Support Level $0.39 $2.20
Resistance Level $0.43 $5.05
Average True Range (ATR) 0.12 1.40
MACD 0.06 -0.31
Stochastic Oscillator 76.46 11.08

Price Performance

Historical Comparison
RXT
PLYX

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

Share on Social Networks: